drugset / Trial / NCT05092503

JINZHEN for Treatment of Mild to Moderate COVID-19

NCT05092503 ↗

Phase 1/2 Completed 60 enrolled Lianyungang Kanion Group, Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

JINZHEN is a botanical drug that contains eight chemical constituents extracted from plant, mineral and animal origin raw materials. This study is to evaluate the safety and efficacy of JINZHEN Granules for Oral Solution compared to placebo for treatment of mild to moderate COVID-19 outpatients.

Timeline

Start
2022-05-26
Primary completion
2023-05-12
Completion
2023-05-12

Drugs

EvaluationDrugModalityDoseRoute
Subject JINZHEN Traditional medicine (herbal / TCM) 0.375 g Oral
Subject JINZHEN Traditional medicine (herbal / TCM) 0.75 g Oral
Subject JINZHEN Traditional medicine (herbal / TCM) 1.5 g Oral

Indications